Global Recombinant Antihemophilic Globulin Supply, Demand and Key Producers, 2023-2029
The global Recombinant Antihemophilic Globulin market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).
The recombinant antihemophilic globulin is a synthetic form of factor VIII that functions similarly to the human-produced clotting factor VIII. It helps hemophilia A patients restore normal coagulation function and prevent or treat bleeding episodes by supplementing deficient coagulation factor VIII. The preparation process of the recombinant antihemophilic globulin includes the following steps: gene cloning, expression vector construction, cell culture and expression, purification and preparation. It has the characteristics of high efficiency, safety and stability, can effectively control and prevent bleeding, and improve the quality of life of hemophilia patients.
The recombinant antihemophilic globulin is a drug synthesized by gene recombination technology, which is used to treat patients with hemophilia A. Hemophilia A is an inherited bleeding disorder caused by deficiency or dysfunction of clotting factor VIII.
This report studies the global Recombinant Antihemophilic Globulin production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Recombinant Antihemophilic Globulin, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Recombinant Antihemophilic Globulin that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Recombinant Antihemophilic Globulin total production and demand, 2018-2029, (Units)
Global Recombinant Antihemophilic Globulin total production value, 2018-2029, (USD Million)
Global Recombinant Antihemophilic Globulin production by region & country, production, value, CAGR, 2018-2029, (USD Million) & (Units)
Global Recombinant Antihemophilic Globulin consumption by region & country, CAGR, 2018-2029 & (Units)
U.S. VS China: Recombinant Antihemophilic Globulin domestic production, consumption, key domestic manufacturers and share
Global Recombinant Antihemophilic Globulin production by manufacturer, production, price, value and market share 2018-2023, (USD Million) & (Units)
Global Recombinant Antihemophilic Globulin production by Type, production, value, CAGR, 2018-2029, (USD Million) & (Units)
Global Recombinant Antihemophilic Globulin production by Application production, value, CAGR, 2018-2029, (USD Million) & (Units).
This reports profiles key players in the global Recombinant Antihemophilic Globulin market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Shire (Baxter), Bayer Healthcare, CSL, Pfizer, Grifols, Biogen, Octapharma, Novo Nordisk and Greencross, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Recombinant Antihemophilic Globulin market.
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Recombinant Antihemophilic Globulin Market, By Region:
1. How big is the global Recombinant Antihemophilic Globulin market?
2. What is the demand of the global Recombinant Antihemophilic Globulin market?
3. What is the year over year growth of the global Recombinant Antihemophilic Globulin market?
4. What is the production and production value of the global Recombinant Antihemophilic Globulin market?
5. Who are the key producers in the global Recombinant Antihemophilic Globulin market?
6. What are the growth factors driving the market demand?
The recombinant antihemophilic globulin is a synthetic form of factor VIII that functions similarly to the human-produced clotting factor VIII. It helps hemophilia A patients restore normal coagulation function and prevent or treat bleeding episodes by supplementing deficient coagulation factor VIII. The preparation process of the recombinant antihemophilic globulin includes the following steps: gene cloning, expression vector construction, cell culture and expression, purification and preparation. It has the characteristics of high efficiency, safety and stability, can effectively control and prevent bleeding, and improve the quality of life of hemophilia patients.
The recombinant antihemophilic globulin is a drug synthesized by gene recombination technology, which is used to treat patients with hemophilia A. Hemophilia A is an inherited bleeding disorder caused by deficiency or dysfunction of clotting factor VIII.
This report studies the global Recombinant Antihemophilic Globulin production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Recombinant Antihemophilic Globulin, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Recombinant Antihemophilic Globulin that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Recombinant Antihemophilic Globulin total production and demand, 2018-2029, (Units)
Global Recombinant Antihemophilic Globulin total production value, 2018-2029, (USD Million)
Global Recombinant Antihemophilic Globulin production by region & country, production, value, CAGR, 2018-2029, (USD Million) & (Units)
Global Recombinant Antihemophilic Globulin consumption by region & country, CAGR, 2018-2029 & (Units)
U.S. VS China: Recombinant Antihemophilic Globulin domestic production, consumption, key domestic manufacturers and share
Global Recombinant Antihemophilic Globulin production by manufacturer, production, price, value and market share 2018-2023, (USD Million) & (Units)
Global Recombinant Antihemophilic Globulin production by Type, production, value, CAGR, 2018-2029, (USD Million) & (Units)
Global Recombinant Antihemophilic Globulin production by Application production, value, CAGR, 2018-2029, (USD Million) & (Units).
This reports profiles key players in the global Recombinant Antihemophilic Globulin market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Shire (Baxter), Bayer Healthcare, CSL, Pfizer, Grifols, Biogen, Octapharma, Novo Nordisk and Greencross, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Recombinant Antihemophilic Globulin market.
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Recombinant Antihemophilic Globulin Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- Baikoc
- Afstyla
- Altuviiio
- Clinical Treatment
- Drug Research
- Others
- Shire (Baxter)
- Bayer Healthcare
- CSL
- Pfizer
- Grifols
- Biogen
- Octapharma
- Novo Nordisk
- Greencross
- Kedrion
- BPL
- Hualan Bio
- RAAS
- Baxalta
1. How big is the global Recombinant Antihemophilic Globulin market?
2. What is the demand of the global Recombinant Antihemophilic Globulin market?
3. What is the year over year growth of the global Recombinant Antihemophilic Globulin market?
4. What is the production and production value of the global Recombinant Antihemophilic Globulin market?
5. Who are the key producers in the global Recombinant Antihemophilic Globulin market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 Recombinant Antihemophilic Globulin Introduction
1.2 World Recombinant Antihemophilic Globulin Supply & Forecast
1.2.1 World Recombinant Antihemophilic Globulin Production Value (2018 & 2022 & 2029)
1.2.2 World Recombinant Antihemophilic Globulin Production (2018-2029)
1.2.3 World Recombinant Antihemophilic Globulin Pricing Trends (2018-2029)
1.3 World Recombinant Antihemophilic Globulin Production by Region (Based on Production Site)
1.3.1 World Recombinant Antihemophilic Globulin Production Value by Region (2018-2029)
1.3.2 World Recombinant Antihemophilic Globulin Production by Region (2018-2029)
1.3.3 World Recombinant Antihemophilic Globulin Average Price by Region (2018-2029)
1.3.4 North America Recombinant Antihemophilic Globulin Production (2018-2029)
1.3.5 Europe Recombinant Antihemophilic Globulin Production (2018-2029)
1.3.6 China Recombinant Antihemophilic Globulin Production (2018-2029)
1.3.7 Japan Recombinant Antihemophilic Globulin Production (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Recombinant Antihemophilic Globulin Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Recombinant Antihemophilic Globulin Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World Recombinant Antihemophilic Globulin Demand (2018-2029)
2.2 World Recombinant Antihemophilic Globulin Consumption by Region
2.2.1 World Recombinant Antihemophilic Globulin Consumption by Region (2018-2023)
2.2.2 World Recombinant Antihemophilic Globulin Consumption Forecast by Region (2024-2029)
2.3 United States Recombinant Antihemophilic Globulin Consumption (2018-2029)
2.4 China Recombinant Antihemophilic Globulin Consumption (2018-2029)
2.5 Europe Recombinant Antihemophilic Globulin Consumption (2018-2029)
2.6 Japan Recombinant Antihemophilic Globulin Consumption (2018-2029)
2.7 South Korea Recombinant Antihemophilic Globulin Consumption (2018-2029)
2.8 ASEAN Recombinant Antihemophilic Globulin Consumption (2018-2029)
2.9 India Recombinant Antihemophilic Globulin Consumption (2018-2029)
3 WORLD RECOMBINANT ANTIHEMOPHILIC GLOBULIN MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Recombinant Antihemophilic Globulin Production Value by Manufacturer (2018-2023)
3.2 World Recombinant Antihemophilic Globulin Production by Manufacturer (2018-2023)
3.3 World Recombinant Antihemophilic Globulin Average Price by Manufacturer (2018-2023)
3.4 Recombinant Antihemophilic Globulin Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Recombinant Antihemophilic Globulin Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Recombinant Antihemophilic Globulin in 2022
3.5.3 Global Concentration Ratios (CR8) for Recombinant Antihemophilic Globulin in 2022
3.6 Recombinant Antihemophilic Globulin Market: Overall Company Footprint Analysis
3.6.1 Recombinant Antihemophilic Globulin Market: Region Footprint
3.6.2 Recombinant Antihemophilic Globulin Market: Company Product Type Footprint
3.6.3 Recombinant Antihemophilic Globulin Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Recombinant Antihemophilic Globulin Production Value Comparison
4.1.1 United States VS China: Recombinant Antihemophilic Globulin Production Value Comparison (2018 & 2022 & 2029)
4.1.2 United States VS China: Recombinant Antihemophilic Globulin Production Value Market Share Comparison (2018 & 2022 & 2029)
4.2 United States VS China: Recombinant Antihemophilic Globulin Production Comparison
4.2.1 United States VS China: Recombinant Antihemophilic Globulin Production Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Recombinant Antihemophilic Globulin Production Market Share Comparison (2018 & 2022 & 2029)
4.3 United States VS China: Recombinant Antihemophilic Globulin Consumption Comparison
4.3.1 United States VS China: Recombinant Antihemophilic Globulin Consumption Comparison (2018 & 2022 & 2029)
4.3.2 United States VS China: Recombinant Antihemophilic Globulin Consumption Market Share Comparison (2018 & 2022 & 2029)
4.4 United States Based Recombinant Antihemophilic Globulin Manufacturers and Market Share, 2018-2023
4.4.1 United States Based Recombinant Antihemophilic Globulin Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Recombinant Antihemophilic Globulin Production Value (2018-2023)
4.4.3 United States Based Manufacturers Recombinant Antihemophilic Globulin Production (2018-2023)
4.5 China Based Recombinant Antihemophilic Globulin Manufacturers and Market Share
4.5.1 China Based Recombinant Antihemophilic Globulin Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Recombinant Antihemophilic Globulin Production Value (2018-2023)
4.5.3 China Based Manufacturers Recombinant Antihemophilic Globulin Production (2018-2023)
4.6 Rest of World Based Recombinant Antihemophilic Globulin Manufacturers and Market Share, 2018-2023
4.6.1 Rest of World Based Recombinant Antihemophilic Globulin Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Recombinant Antihemophilic Globulin Production Value (2018-2023)
4.6.3 Rest of World Based Manufacturers Recombinant Antihemophilic Globulin Production (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World Recombinant Antihemophilic Globulin Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Baikoc
5.2.2 Afstyla
5.2.3 Altuviiio
5.3 Market Segment by Type
5.3.1 World Recombinant Antihemophilic Globulin Production by Type (2018-2029)
5.3.2 World Recombinant Antihemophilic Globulin Production Value by Type (2018-2029)
5.3.3 World Recombinant Antihemophilic Globulin Average Price by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Recombinant Antihemophilic Globulin Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Clinical Treatment
6.2.2 Drug Research
6.2.3 Others
6.3 Market Segment by Application
6.3.1 World Recombinant Antihemophilic Globulin Production by Application (2018-2029)
6.3.2 World Recombinant Antihemophilic Globulin Production Value by Application (2018-2029)
6.3.3 World Recombinant Antihemophilic Globulin Average Price by Application (2018-2029)
7 COMPANY PROFILES
7.1 Shire (Baxter)
7.1.1 Shire (Baxter) Details
7.1.2 Shire (Baxter) Major Business
7.1.3 Shire (Baxter) Recombinant Antihemophilic Globulin Product and Services
7.1.4 Shire (Baxter) Recombinant Antihemophilic Globulin Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.1.5 Shire (Baxter) Recent Developments/Updates
7.1.6 Shire (Baxter) Competitive Strengths & Weaknesses
7.2 Bayer Healthcare
7.2.1 Bayer Healthcare Details
7.2.2 Bayer Healthcare Major Business
7.2.3 Bayer Healthcare Recombinant Antihemophilic Globulin Product and Services
7.2.4 Bayer Healthcare Recombinant Antihemophilic Globulin Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.2.5 Bayer Healthcare Recent Developments/Updates
7.2.6 Bayer Healthcare Competitive Strengths & Weaknesses
7.3 CSL
7.3.1 CSL Details
7.3.2 CSL Major Business
7.3.3 CSL Recombinant Antihemophilic Globulin Product and Services
7.3.4 CSL Recombinant Antihemophilic Globulin Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.3.5 CSL Recent Developments/Updates
7.3.6 CSL Competitive Strengths & Weaknesses
7.4 Pfizer
7.4.1 Pfizer Details
7.4.2 Pfizer Major Business
7.4.3 Pfizer Recombinant Antihemophilic Globulin Product and Services
7.4.4 Pfizer Recombinant Antihemophilic Globulin Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.4.5 Pfizer Recent Developments/Updates
7.4.6 Pfizer Competitive Strengths & Weaknesses
7.5 Grifols
7.5.1 Grifols Details
7.5.2 Grifols Major Business
7.5.3 Grifols Recombinant Antihemophilic Globulin Product and Services
7.5.4 Grifols Recombinant Antihemophilic Globulin Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.5.5 Grifols Recent Developments/Updates
7.5.6 Grifols Competitive Strengths & Weaknesses
7.6 Biogen
7.6.1 Biogen Details
7.6.2 Biogen Major Business
7.6.3 Biogen Recombinant Antihemophilic Globulin Product and Services
7.6.4 Biogen Recombinant Antihemophilic Globulin Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.6.5 Biogen Recent Developments/Updates
7.6.6 Biogen Competitive Strengths & Weaknesses
7.7 Octapharma
7.7.1 Octapharma Details
7.7.2 Octapharma Major Business
7.7.3 Octapharma Recombinant Antihemophilic Globulin Product and Services
7.7.4 Octapharma Recombinant Antihemophilic Globulin Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.7.5 Octapharma Recent Developments/Updates
7.7.6 Octapharma Competitive Strengths & Weaknesses
7.8 Novo Nordisk
7.8.1 Novo Nordisk Details
7.8.2 Novo Nordisk Major Business
7.8.3 Novo Nordisk Recombinant Antihemophilic Globulin Product and Services
7.8.4 Novo Nordisk Recombinant Antihemophilic Globulin Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.8.5 Novo Nordisk Recent Developments/Updates
7.8.6 Novo Nordisk Competitive Strengths & Weaknesses
7.9 Greencross
7.9.1 Greencross Details
7.9.2 Greencross Major Business
7.9.3 Greencross Recombinant Antihemophilic Globulin Product and Services
7.9.4 Greencross Recombinant Antihemophilic Globulin Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.9.5 Greencross Recent Developments/Updates
7.9.6 Greencross Competitive Strengths & Weaknesses
7.10 Kedrion
7.10.1 Kedrion Details
7.10.2 Kedrion Major Business
7.10.3 Kedrion Recombinant Antihemophilic Globulin Product and Services
7.10.4 Kedrion Recombinant Antihemophilic Globulin Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.10.5 Kedrion Recent Developments/Updates
7.10.6 Kedrion Competitive Strengths & Weaknesses
7.11 BPL
7.11.1 BPL Details
7.11.2 BPL Major Business
7.11.3 BPL Recombinant Antihemophilic Globulin Product and Services
7.11.4 BPL Recombinant Antihemophilic Globulin Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.11.5 BPL Recent Developments/Updates
7.11.6 BPL Competitive Strengths & Weaknesses
7.12 Hualan Bio
7.12.1 Hualan Bio Details
7.12.2 Hualan Bio Major Business
7.12.3 Hualan Bio Recombinant Antihemophilic Globulin Product and Services
7.12.4 Hualan Bio Recombinant Antihemophilic Globulin Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.12.5 Hualan Bio Recent Developments/Updates
7.12.6 Hualan Bio Competitive Strengths & Weaknesses
7.13 RAAS
7.13.1 RAAS Details
7.13.2 RAAS Major Business
7.13.3 RAAS Recombinant Antihemophilic Globulin Product and Services
7.13.4 RAAS Recombinant Antihemophilic Globulin Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.13.5 RAAS Recent Developments/Updates
7.13.6 RAAS Competitive Strengths & Weaknesses
7.14 Baxalta
7.14.1 Baxalta Details
7.14.2 Baxalta Major Business
7.14.3 Baxalta Recombinant Antihemophilic Globulin Product and Services
7.14.4 Baxalta Recombinant Antihemophilic Globulin Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.14.5 Baxalta Recent Developments/Updates
7.14.6 Baxalta Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Recombinant Antihemophilic Globulin Industry Chain
8.2 Recombinant Antihemophilic Globulin Upstream Analysis
8.2.1 Recombinant Antihemophilic Globulin Core Raw Materials
8.2.2 Main Manufacturers of Recombinant Antihemophilic Globulin Core Raw Materials
8.3 Midstream Analysis
8.4 Downstream Analysis
8.5 Recombinant Antihemophilic Globulin Production Mode
8.6 Recombinant Antihemophilic Globulin Procurement Model
8.7 Recombinant Antihemophilic Globulin Industry Sales Model and Sales Channels
8.7.1 Recombinant Antihemophilic Globulin Sales Model
8.7.2 Recombinant Antihemophilic Globulin Typical Customers
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
1.1 Recombinant Antihemophilic Globulin Introduction
1.2 World Recombinant Antihemophilic Globulin Supply & Forecast
1.2.1 World Recombinant Antihemophilic Globulin Production Value (2018 & 2022 & 2029)
1.2.2 World Recombinant Antihemophilic Globulin Production (2018-2029)
1.2.3 World Recombinant Antihemophilic Globulin Pricing Trends (2018-2029)
1.3 World Recombinant Antihemophilic Globulin Production by Region (Based on Production Site)
1.3.1 World Recombinant Antihemophilic Globulin Production Value by Region (2018-2029)
1.3.2 World Recombinant Antihemophilic Globulin Production by Region (2018-2029)
1.3.3 World Recombinant Antihemophilic Globulin Average Price by Region (2018-2029)
1.3.4 North America Recombinant Antihemophilic Globulin Production (2018-2029)
1.3.5 Europe Recombinant Antihemophilic Globulin Production (2018-2029)
1.3.6 China Recombinant Antihemophilic Globulin Production (2018-2029)
1.3.7 Japan Recombinant Antihemophilic Globulin Production (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Recombinant Antihemophilic Globulin Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Recombinant Antihemophilic Globulin Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World Recombinant Antihemophilic Globulin Demand (2018-2029)
2.2 World Recombinant Antihemophilic Globulin Consumption by Region
2.2.1 World Recombinant Antihemophilic Globulin Consumption by Region (2018-2023)
2.2.2 World Recombinant Antihemophilic Globulin Consumption Forecast by Region (2024-2029)
2.3 United States Recombinant Antihemophilic Globulin Consumption (2018-2029)
2.4 China Recombinant Antihemophilic Globulin Consumption (2018-2029)
2.5 Europe Recombinant Antihemophilic Globulin Consumption (2018-2029)
2.6 Japan Recombinant Antihemophilic Globulin Consumption (2018-2029)
2.7 South Korea Recombinant Antihemophilic Globulin Consumption (2018-2029)
2.8 ASEAN Recombinant Antihemophilic Globulin Consumption (2018-2029)
2.9 India Recombinant Antihemophilic Globulin Consumption (2018-2029)
3 WORLD RECOMBINANT ANTIHEMOPHILIC GLOBULIN MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Recombinant Antihemophilic Globulin Production Value by Manufacturer (2018-2023)
3.2 World Recombinant Antihemophilic Globulin Production by Manufacturer (2018-2023)
3.3 World Recombinant Antihemophilic Globulin Average Price by Manufacturer (2018-2023)
3.4 Recombinant Antihemophilic Globulin Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Recombinant Antihemophilic Globulin Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Recombinant Antihemophilic Globulin in 2022
3.5.3 Global Concentration Ratios (CR8) for Recombinant Antihemophilic Globulin in 2022
3.6 Recombinant Antihemophilic Globulin Market: Overall Company Footprint Analysis
3.6.1 Recombinant Antihemophilic Globulin Market: Region Footprint
3.6.2 Recombinant Antihemophilic Globulin Market: Company Product Type Footprint
3.6.3 Recombinant Antihemophilic Globulin Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Recombinant Antihemophilic Globulin Production Value Comparison
4.1.1 United States VS China: Recombinant Antihemophilic Globulin Production Value Comparison (2018 & 2022 & 2029)
4.1.2 United States VS China: Recombinant Antihemophilic Globulin Production Value Market Share Comparison (2018 & 2022 & 2029)
4.2 United States VS China: Recombinant Antihemophilic Globulin Production Comparison
4.2.1 United States VS China: Recombinant Antihemophilic Globulin Production Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Recombinant Antihemophilic Globulin Production Market Share Comparison (2018 & 2022 & 2029)
4.3 United States VS China: Recombinant Antihemophilic Globulin Consumption Comparison
4.3.1 United States VS China: Recombinant Antihemophilic Globulin Consumption Comparison (2018 & 2022 & 2029)
4.3.2 United States VS China: Recombinant Antihemophilic Globulin Consumption Market Share Comparison (2018 & 2022 & 2029)
4.4 United States Based Recombinant Antihemophilic Globulin Manufacturers and Market Share, 2018-2023
4.4.1 United States Based Recombinant Antihemophilic Globulin Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Recombinant Antihemophilic Globulin Production Value (2018-2023)
4.4.3 United States Based Manufacturers Recombinant Antihemophilic Globulin Production (2018-2023)
4.5 China Based Recombinant Antihemophilic Globulin Manufacturers and Market Share
4.5.1 China Based Recombinant Antihemophilic Globulin Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Recombinant Antihemophilic Globulin Production Value (2018-2023)
4.5.3 China Based Manufacturers Recombinant Antihemophilic Globulin Production (2018-2023)
4.6 Rest of World Based Recombinant Antihemophilic Globulin Manufacturers and Market Share, 2018-2023
4.6.1 Rest of World Based Recombinant Antihemophilic Globulin Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Recombinant Antihemophilic Globulin Production Value (2018-2023)
4.6.3 Rest of World Based Manufacturers Recombinant Antihemophilic Globulin Production (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World Recombinant Antihemophilic Globulin Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Baikoc
5.2.2 Afstyla
5.2.3 Altuviiio
5.3 Market Segment by Type
5.3.1 World Recombinant Antihemophilic Globulin Production by Type (2018-2029)
5.3.2 World Recombinant Antihemophilic Globulin Production Value by Type (2018-2029)
5.3.3 World Recombinant Antihemophilic Globulin Average Price by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Recombinant Antihemophilic Globulin Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Clinical Treatment
6.2.2 Drug Research
6.2.3 Others
6.3 Market Segment by Application
6.3.1 World Recombinant Antihemophilic Globulin Production by Application (2018-2029)
6.3.2 World Recombinant Antihemophilic Globulin Production Value by Application (2018-2029)
6.3.3 World Recombinant Antihemophilic Globulin Average Price by Application (2018-2029)
7 COMPANY PROFILES
7.1 Shire (Baxter)
7.1.1 Shire (Baxter) Details
7.1.2 Shire (Baxter) Major Business
7.1.3 Shire (Baxter) Recombinant Antihemophilic Globulin Product and Services
7.1.4 Shire (Baxter) Recombinant Antihemophilic Globulin Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.1.5 Shire (Baxter) Recent Developments/Updates
7.1.6 Shire (Baxter) Competitive Strengths & Weaknesses
7.2 Bayer Healthcare
7.2.1 Bayer Healthcare Details
7.2.2 Bayer Healthcare Major Business
7.2.3 Bayer Healthcare Recombinant Antihemophilic Globulin Product and Services
7.2.4 Bayer Healthcare Recombinant Antihemophilic Globulin Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.2.5 Bayer Healthcare Recent Developments/Updates
7.2.6 Bayer Healthcare Competitive Strengths & Weaknesses
7.3 CSL
7.3.1 CSL Details
7.3.2 CSL Major Business
7.3.3 CSL Recombinant Antihemophilic Globulin Product and Services
7.3.4 CSL Recombinant Antihemophilic Globulin Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.3.5 CSL Recent Developments/Updates
7.3.6 CSL Competitive Strengths & Weaknesses
7.4 Pfizer
7.4.1 Pfizer Details
7.4.2 Pfizer Major Business
7.4.3 Pfizer Recombinant Antihemophilic Globulin Product and Services
7.4.4 Pfizer Recombinant Antihemophilic Globulin Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.4.5 Pfizer Recent Developments/Updates
7.4.6 Pfizer Competitive Strengths & Weaknesses
7.5 Grifols
7.5.1 Grifols Details
7.5.2 Grifols Major Business
7.5.3 Grifols Recombinant Antihemophilic Globulin Product and Services
7.5.4 Grifols Recombinant Antihemophilic Globulin Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.5.5 Grifols Recent Developments/Updates
7.5.6 Grifols Competitive Strengths & Weaknesses
7.6 Biogen
7.6.1 Biogen Details
7.6.2 Biogen Major Business
7.6.3 Biogen Recombinant Antihemophilic Globulin Product and Services
7.6.4 Biogen Recombinant Antihemophilic Globulin Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.6.5 Biogen Recent Developments/Updates
7.6.6 Biogen Competitive Strengths & Weaknesses
7.7 Octapharma
7.7.1 Octapharma Details
7.7.2 Octapharma Major Business
7.7.3 Octapharma Recombinant Antihemophilic Globulin Product and Services
7.7.4 Octapharma Recombinant Antihemophilic Globulin Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.7.5 Octapharma Recent Developments/Updates
7.7.6 Octapharma Competitive Strengths & Weaknesses
7.8 Novo Nordisk
7.8.1 Novo Nordisk Details
7.8.2 Novo Nordisk Major Business
7.8.3 Novo Nordisk Recombinant Antihemophilic Globulin Product and Services
7.8.4 Novo Nordisk Recombinant Antihemophilic Globulin Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.8.5 Novo Nordisk Recent Developments/Updates
7.8.6 Novo Nordisk Competitive Strengths & Weaknesses
7.9 Greencross
7.9.1 Greencross Details
7.9.2 Greencross Major Business
7.9.3 Greencross Recombinant Antihemophilic Globulin Product and Services
7.9.4 Greencross Recombinant Antihemophilic Globulin Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.9.5 Greencross Recent Developments/Updates
7.9.6 Greencross Competitive Strengths & Weaknesses
7.10 Kedrion
7.10.1 Kedrion Details
7.10.2 Kedrion Major Business
7.10.3 Kedrion Recombinant Antihemophilic Globulin Product and Services
7.10.4 Kedrion Recombinant Antihemophilic Globulin Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.10.5 Kedrion Recent Developments/Updates
7.10.6 Kedrion Competitive Strengths & Weaknesses
7.11 BPL
7.11.1 BPL Details
7.11.2 BPL Major Business
7.11.3 BPL Recombinant Antihemophilic Globulin Product and Services
7.11.4 BPL Recombinant Antihemophilic Globulin Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.11.5 BPL Recent Developments/Updates
7.11.6 BPL Competitive Strengths & Weaknesses
7.12 Hualan Bio
7.12.1 Hualan Bio Details
7.12.2 Hualan Bio Major Business
7.12.3 Hualan Bio Recombinant Antihemophilic Globulin Product and Services
7.12.4 Hualan Bio Recombinant Antihemophilic Globulin Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.12.5 Hualan Bio Recent Developments/Updates
7.12.6 Hualan Bio Competitive Strengths & Weaknesses
7.13 RAAS
7.13.1 RAAS Details
7.13.2 RAAS Major Business
7.13.3 RAAS Recombinant Antihemophilic Globulin Product and Services
7.13.4 RAAS Recombinant Antihemophilic Globulin Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.13.5 RAAS Recent Developments/Updates
7.13.6 RAAS Competitive Strengths & Weaknesses
7.14 Baxalta
7.14.1 Baxalta Details
7.14.2 Baxalta Major Business
7.14.3 Baxalta Recombinant Antihemophilic Globulin Product and Services
7.14.4 Baxalta Recombinant Antihemophilic Globulin Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.14.5 Baxalta Recent Developments/Updates
7.14.6 Baxalta Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Recombinant Antihemophilic Globulin Industry Chain
8.2 Recombinant Antihemophilic Globulin Upstream Analysis
8.2.1 Recombinant Antihemophilic Globulin Core Raw Materials
8.2.2 Main Manufacturers of Recombinant Antihemophilic Globulin Core Raw Materials
8.3 Midstream Analysis
8.4 Downstream Analysis
8.5 Recombinant Antihemophilic Globulin Production Mode
8.6 Recombinant Antihemophilic Globulin Procurement Model
8.7 Recombinant Antihemophilic Globulin Industry Sales Model and Sales Channels
8.7.1 Recombinant Antihemophilic Globulin Sales Model
8.7.2 Recombinant Antihemophilic Globulin Typical Customers
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
LIST OF TABLES
Table 1. World Recombinant Antihemophilic Globulin Production Value by Region (2018, 2022 and 2029) & (USD Million)
Table 2. World Recombinant Antihemophilic Globulin Production Value by Region (2018-2023) & (USD Million)
Table 3. World Recombinant Antihemophilic Globulin Production Value by Region (2024-2029) & (USD Million)
Table 4. World Recombinant Antihemophilic Globulin Production Value Market Share by Region (2018-2023)
Table 5. World Recombinant Antihemophilic Globulin Production Value Market Share by Region (2024-2029)
Table 6. World Recombinant Antihemophilic Globulin Production by Region (2018-2023) & (Units)
Table 7. World Recombinant Antihemophilic Globulin Production by Region (2024-2029) & (Units)
Table 8. World Recombinant Antihemophilic Globulin Production Market Share by Region (2018-2023)
Table 9. World Recombinant Antihemophilic Globulin Production Market Share by Region (2024-2029)
Table 10. World Recombinant Antihemophilic Globulin Average Price by Region (2018-2023) & (US$/Unit)
Table 11. World Recombinant Antihemophilic Globulin Average Price by Region (2024-2029) & (US$/Unit)
Table 12. Recombinant Antihemophilic Globulin Major Market Trends
Table 13. World Recombinant Antihemophilic Globulin Consumption Growth Rate Forecast by Region (2018 & 2022 & 2029) & (Units)
Table 14. World Recombinant Antihemophilic Globulin Consumption by Region (2018-2023) & (Units)
Table 15. World Recombinant Antihemophilic Globulin Consumption Forecast by Region (2024-2029) & (Units)
Table 16. World Recombinant Antihemophilic Globulin Production Value by Manufacturer (2018-2023) & (USD Million)
Table 17. Production Value Market Share of Key Recombinant Antihemophilic Globulin Producers in 2022
Table 18. World Recombinant Antihemophilic Globulin Production by Manufacturer (2018-2023) & (Units)
Table 19. Production Market Share of Key Recombinant Antihemophilic Globulin Producers in 2022
Table 20. World Recombinant Antihemophilic Globulin Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 21. Global Recombinant Antihemophilic Globulin Company Evaluation Quadrant
Table 22. World Recombinant Antihemophilic Globulin Industry Rank of Major Manufacturers, Based on Production Value in 2022
Table 23. Head Office and Recombinant Antihemophilic Globulin Production Site of Key Manufacturer
Table 24. Recombinant Antihemophilic Globulin Market: Company Product Type Footprint
Table 25. Recombinant Antihemophilic Globulin Market: Company Product Application Footprint
Table 26. Recombinant Antihemophilic Globulin Competitive Factors
Table 27. Recombinant Antihemophilic Globulin New Entrant and Capacity Expansion Plans
Table 28. Recombinant Antihemophilic Globulin Mergers & Acquisitions Activity
Table 29. United States VS China Recombinant Antihemophilic Globulin Production Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 30. United States VS China Recombinant Antihemophilic Globulin Production Comparison, (2018 & 2022 & 2029) & (Units)
Table 31. United States VS China Recombinant Antihemophilic Globulin Consumption Comparison, (2018 & 2022 & 2029) & (Units)
Table 32. United States Based Recombinant Antihemophilic Globulin Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Recombinant Antihemophilic Globulin Production Value, (2018-2023) & (USD Million)
Table 34. United States Based Manufacturers Recombinant Antihemophilic Globulin Production Value Market Share (2018-2023)
Table 35. United States Based Manufacturers Recombinant Antihemophilic Globulin Production (2018-2023) & (Units)
Table 36. United States Based Manufacturers Recombinant Antihemophilic Globulin Production Market Share (2018-2023)
Table 37. China Based Recombinant Antihemophilic Globulin Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Recombinant Antihemophilic Globulin Production Value, (2018-2023) & (USD Million)
Table 39. China Based Manufacturers Recombinant Antihemophilic Globulin Production Value Market Share (2018-2023)
Table 40. China Based Manufacturers Recombinant Antihemophilic Globulin Production (2018-2023) & (Units)
Table 41. China Based Manufacturers Recombinant Antihemophilic Globulin Production Market Share (2018-2023)
Table 42. Rest of World Based Recombinant Antihemophilic Globulin Manufacturers, Headquarters and Production Site (States, Country)
Table 43. Rest of World Based Manufacturers Recombinant Antihemophilic Globulin Production Value, (2018-2023) & (USD Million)
Table 44. Rest of World Based Manufacturers Recombinant Antihemophilic Globulin Production Value Market Share (2018-2023)
Table 45. Rest of World Based Manufacturers Recombinant Antihemophilic Globulin Production (2018-2023) & (Units)
Table 46. Rest of World Based Manufacturers Recombinant Antihemophilic Globulin Production Market Share (2018-2023)
Table 47. World Recombinant Antihemophilic Globulin Production Value by Type, (USD Million), 2018 & 2022 & 2029
Table 48. World Recombinant Antihemophilic Globulin Production by Type (2018-2023) & (Units)
Table 49. World Recombinant Antihemophilic Globulin Production by Type (2024-2029) & (Units)
Table 50. World Recombinant Antihemophilic Globulin Production Value by Type (2018-2023) & (USD Million)
Table 51. World Recombinant Antihemophilic Globulin Production Value by Type (2024-2029) & (USD Million)
Table 52. World Recombinant Antihemophilic Globulin Average Price by Type (2018-2023) & (US$/Unit)
Table 53. World Recombinant Antihemophilic Globulin Average Price by Type (2024-2029) & (US$/Unit)
Table 54. World Recombinant Antihemophilic Globulin Production Value by Application, (USD Million), 2018 & 2022 & 2029
Table 55. World Recombinant Antihemophilic Globulin Production by Application (2018-2023) & (Units)
Table 56. World Recombinant Antihemophilic Globulin Production by Application (2024-2029) & (Units)
Table 57. World Recombinant Antihemophilic Globulin Production Value by Application (2018-2023) & (USD Million)
Table 58. World Recombinant Antihemophilic Globulin Production Value by Application (2024-2029) & (USD Million)
Table 59. World Recombinant Antihemophilic Globulin Average Price by Application (2018-2023) & (US$/Unit)
Table 60. World Recombinant Antihemophilic Globulin Average Price by Application (2024-2029) & (US$/Unit)
Table 61. Shire (Baxter) Basic Information, Manufacturing Base and Competitors
Table 62. Shire (Baxter) Major Business
Table 63. Shire (Baxter) Recombinant Antihemophilic Globulin Product and Services
Table 64. Shire (Baxter) Recombinant Antihemophilic Globulin Production (Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 65. Shire (Baxter) Recent Developments/Updates
Table 66. Shire (Baxter) Competitive Strengths & Weaknesses
Table 67. Bayer Healthcare Basic Information, Manufacturing Base and Competitors
Table 68. Bayer Healthcare Major Business
Table 69. Bayer Healthcare Recombinant Antihemophilic Globulin Product and Services
Table 70. Bayer Healthcare Recombinant Antihemophilic Globulin Production (Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 71. Bayer Healthcare Recent Developments/Updates
Table 72. Bayer Healthcare Competitive Strengths & Weaknesses
Table 73. CSL Basic Information, Manufacturing Base and Competitors
Table 74. CSL Major Business
Table 75. CSL Recombinant Antihemophilic Globulin Product and Services
Table 76. CSL Recombinant Antihemophilic Globulin Production (Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 77. CSL Recent Developments/Updates
Table 78. CSL Competitive Strengths & Weaknesses
Table 79. Pfizer Basic Information, Manufacturing Base and Competitors
Table 80. Pfizer Major Business
Table 81. Pfizer Recombinant Antihemophilic Globulin Product and Services
Table 82. Pfizer Recombinant Antihemophilic Globulin Production (Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 83. Pfizer Recent Developments/Updates
Table 84. Pfizer Competitive Strengths & Weaknesses
Table 85. Grifols Basic Information, Manufacturing Base and Competitors
Table 86. Grifols Major Business
Table 87. Grifols Recombinant Antihemophilic Globulin Product and Services
Table 88. Grifols Recombinant Antihemophilic Globulin Production (Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 89. Grifols Recent Developments/Updates
Table 90. Grifols Competitive Strengths & Weaknesses
Table 91. Biogen Basic Information, Manufacturing Base and Competitors
Table 92. Biogen Major Business
Table 93. Biogen Recombinant Antihemophilic Globulin Product and Services
Table 94. Biogen Recombinant Antihemophilic Globulin Production (Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 95. Biogen Recent Developments/Updates
Table 96. Biogen Competitive Strengths & Weaknesses
Table 97. Octapharma Basic Information, Manufacturing Base and Competitors
Table 98. Octapharma Major Business
Table 99. Octapharma Recombinant Antihemophilic Globulin Product and Services
Table 100. Octapharma Recombinant Antihemophilic Globulin Production (Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 101. Octapharma Recent Developments/Updates
Table 102. Octapharma Competitive Strengths & Weaknesses
Table 103. Novo Nordisk Basic Information, Manufacturing Base and Competitors
Table 104. Novo Nordisk Major Business
Table 105. Novo Nordisk Recombinant Antihemophilic Globulin Product and Services
Table 106. Novo Nordisk Recombinant Antihemophilic Globulin Production (Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 107. Novo Nordisk Recent Developments/Updates
Table 108. Novo Nordisk Competitive Strengths & Weaknesses
Table 109. Greencross Basic Information, Manufacturing Base and Competitors
Table 110. Greencross Major Business
Table 111. Greencross Recombinant Antihemophilic Globulin Product and Services
Table 112. Greencross Recombinant Antihemophilic Globulin Production (Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 113. Greencross Recent Developments/Updates
Table 114. Greencross Competitive Strengths & Weaknesses
Table 115. Kedrion Basic Information, Manufacturing Base and Competitors
Table 116. Kedrion Major Business
Table 117. Kedrion Recombinant Antihemophilic Globulin Product and Services
Table 118. Kedrion Recombinant Antihemophilic Globulin Production (Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 119. Kedrion Recent Developments/Updates
Table 120. Kedrion Competitive Strengths & Weaknesses
Table 121. BPL Basic Information, Manufacturing Base and Competitors
Table 122. BPL Major Business
Table 123. BPL Recombinant Antihemophilic Globulin Product and Services
Table 124. BPL Recombinant Antihemophilic Globulin Production (Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 125. BPL Recent Developments/Updates
Table 126. BPL Competitive Strengths & Weaknesses
Table 127. Hualan Bio Basic Information, Manufacturing Base and Competitors
Table 128. Hualan Bio Major Business
Table 129. Hualan Bio Recombinant Antihemophilic Globulin Product and Services
Table 130. Hualan Bio Recombinant Antihemophilic Globulin Production (Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 131. Hualan Bio Recent Developments/Updates
Table 132. Hualan Bio Competitive Strengths & Weaknesses
Table 133. RAAS Basic Information, Manufacturing Base and Competitors
Table 134. RAAS Major Business
Table 135. RAAS Recombinant Antihemophilic Globulin Product and Services
Table 136. RAAS Recombinant Antihemophilic Globulin Production (Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 137. RAAS Recent Developments/Updates
Table 138. Baxalta Basic Information, Manufacturing Base and Competitors
Table 139. Baxalta Major Business
Table 140. Baxalta Recombinant Antihemophilic Globulin Product and Services
Table 141. Baxalta Recombinant Antihemophilic Globulin Production (Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 142. Global Key Players of Recombinant Antihemophilic Globulin Upstream (Raw Materials)
Table 143. Recombinant Antihemophilic Globulin Typical Customers
Table 144. Recombinant Antihemophilic Globulin Typical Distributors
List of Figure
Figure 1. Recombinant Antihemophilic Globulin Picture
Figure 2. World Recombinant Antihemophilic Globulin Production Value: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Recombinant Antihemophilic Globulin Production Value and Forecast (2018-2029) & (USD Million)
Figure 4. World Recombinant Antihemophilic Globulin Production (2018-2029) & (Units)
Figure 5. World Recombinant Antihemophilic Globulin Average Price (2018-2029) & (US$/Unit)
Figure 6. World Recombinant Antihemophilic Globulin Production Value Market Share by Region (2018-2029)
Figure 7. World Recombinant Antihemophilic Globulin Production Market Share by Region (2018-2029)
Figure 8. North America Recombinant Antihemophilic Globulin Production (2018-2029) & (Units)
Figure 9. Europe Recombinant Antihemophilic Globulin Production (2018-2029) & (Units)
Figure 10. China Recombinant Antihemophilic Globulin Production (2018-2029) & (Units)
Figure 11. Japan Recombinant Antihemophilic Globulin Production (2018-2029) & (Units)
Figure 12. Recombinant Antihemophilic Globulin Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Recombinant Antihemophilic Globulin Consumption (2018-2029) & (Units)
Figure 15. World Recombinant Antihemophilic Globulin Consumption Market Share by Region (2018-2029)
Figure 16. United States Recombinant Antihemophilic Globulin Consumption (2018-2029) & (Units)
Figure 17. China Recombinant Antihemophilic Globulin Consumption (2018-2029) & (Units)
Figure 18. Europe Recombinant Antihemophilic Globulin Consumption (2018-2029) & (Units)
Figure 19. Japan Recombinant Antihemophilic Globulin Consumption (2018-2029) & (Units)
Figure 20. South Korea Recombinant Antihemophilic Globulin Consumption (2018-2029) & (Units)
Figure 21. ASEAN Recombinant Antihemophilic Globulin Consumption (2018-2029) & (Units)
Figure 22. India Recombinant Antihemophilic Globulin Consumption (2018-2029) & (Units)
Figure 23. Producer Shipments of Recombinant Antihemophilic Globulin by Manufacturer Revenue ($MM) and Market Share (%): 2022
Figure 24. Global Four-firm Concentration Ratios (CR4) for Recombinant Antihemophilic Globulin Markets in 2022
Figure 25. Global Four-firm Concentration Ratios (CR8) for Recombinant Antihemophilic Globulin Markets in 2022
Figure 26. United States VS China: Recombinant Antihemophilic Globulin Production Value Market Share Comparison (2018 & 2022 & 2029)
Figure 27. United States VS China: Recombinant Antihemophilic Globulin Production Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Recombinant Antihemophilic Globulin Consumption Market Share Comparison (2018 & 2022 & 2029)
Figure 29. United States Based Manufacturers Recombinant Antihemophilic Globulin Production Market Share 2022
Figure 30. China Based Manufacturers Recombinant Antihemophilic Globulin Production Market Share 2022
Figure 31. Rest of World Based Manufacturers Recombinant Antihemophilic Globulin Production Market Share 2022
Figure 32. World Recombinant Antihemophilic Globulin Production Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 33. World Recombinant Antihemophilic Globulin Production Value Market Share by Type in 2022
Figure 34. Baikoc
Figure 35. Afstyla
Figure 36. Altuviiio
Figure 37. World Recombinant Antihemophilic Globulin Production Market Share by Type (2018-2029)
Figure 38. World Recombinant Antihemophilic Globulin Production Value Market Share by Type (2018-2029)
Figure 39. World Recombinant Antihemophilic Globulin Average Price by Type (2018-2029) & (US$/Unit)
Figure 40. World Recombinant Antihemophilic Globulin Production Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 41. World Recombinant Antihemophilic Globulin Production Value Market Share by Application in 2022
Figure 42. Clinical Treatment
Figure 43. Drug Research
Figure 44. Others
Figure 45. World Recombinant Antihemophilic Globulin Production Market Share by Application (2018-2029)
Figure 46. World Recombinant Antihemophilic Globulin Production Value Market Share by Application (2018-2029)
Figure 47. World Recombinant Antihemophilic Globulin Average Price by Application (2018-2029) & (US$/Unit)
Figure 48. Recombinant Antihemophilic Globulin Industry Chain
Figure 49. Recombinant Antihemophilic Globulin Procurement Model
Figure 50. Recombinant Antihemophilic Globulin Sales Model
Figure 51. Recombinant Antihemophilic Globulin Sales Channels, Direct Sales, and Distribution
Figure 52. Methodology
Figure 53. Research Process and Data Source
Table 1. World Recombinant Antihemophilic Globulin Production Value by Region (2018, 2022 and 2029) & (USD Million)
Table 2. World Recombinant Antihemophilic Globulin Production Value by Region (2018-2023) & (USD Million)
Table 3. World Recombinant Antihemophilic Globulin Production Value by Region (2024-2029) & (USD Million)
Table 4. World Recombinant Antihemophilic Globulin Production Value Market Share by Region (2018-2023)
Table 5. World Recombinant Antihemophilic Globulin Production Value Market Share by Region (2024-2029)
Table 6. World Recombinant Antihemophilic Globulin Production by Region (2018-2023) & (Units)
Table 7. World Recombinant Antihemophilic Globulin Production by Region (2024-2029) & (Units)
Table 8. World Recombinant Antihemophilic Globulin Production Market Share by Region (2018-2023)
Table 9. World Recombinant Antihemophilic Globulin Production Market Share by Region (2024-2029)
Table 10. World Recombinant Antihemophilic Globulin Average Price by Region (2018-2023) & (US$/Unit)
Table 11. World Recombinant Antihemophilic Globulin Average Price by Region (2024-2029) & (US$/Unit)
Table 12. Recombinant Antihemophilic Globulin Major Market Trends
Table 13. World Recombinant Antihemophilic Globulin Consumption Growth Rate Forecast by Region (2018 & 2022 & 2029) & (Units)
Table 14. World Recombinant Antihemophilic Globulin Consumption by Region (2018-2023) & (Units)
Table 15. World Recombinant Antihemophilic Globulin Consumption Forecast by Region (2024-2029) & (Units)
Table 16. World Recombinant Antihemophilic Globulin Production Value by Manufacturer (2018-2023) & (USD Million)
Table 17. Production Value Market Share of Key Recombinant Antihemophilic Globulin Producers in 2022
Table 18. World Recombinant Antihemophilic Globulin Production by Manufacturer (2018-2023) & (Units)
Table 19. Production Market Share of Key Recombinant Antihemophilic Globulin Producers in 2022
Table 20. World Recombinant Antihemophilic Globulin Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 21. Global Recombinant Antihemophilic Globulin Company Evaluation Quadrant
Table 22. World Recombinant Antihemophilic Globulin Industry Rank of Major Manufacturers, Based on Production Value in 2022
Table 23. Head Office and Recombinant Antihemophilic Globulin Production Site of Key Manufacturer
Table 24. Recombinant Antihemophilic Globulin Market: Company Product Type Footprint
Table 25. Recombinant Antihemophilic Globulin Market: Company Product Application Footprint
Table 26. Recombinant Antihemophilic Globulin Competitive Factors
Table 27. Recombinant Antihemophilic Globulin New Entrant and Capacity Expansion Plans
Table 28. Recombinant Antihemophilic Globulin Mergers & Acquisitions Activity
Table 29. United States VS China Recombinant Antihemophilic Globulin Production Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 30. United States VS China Recombinant Antihemophilic Globulin Production Comparison, (2018 & 2022 & 2029) & (Units)
Table 31. United States VS China Recombinant Antihemophilic Globulin Consumption Comparison, (2018 & 2022 & 2029) & (Units)
Table 32. United States Based Recombinant Antihemophilic Globulin Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Recombinant Antihemophilic Globulin Production Value, (2018-2023) & (USD Million)
Table 34. United States Based Manufacturers Recombinant Antihemophilic Globulin Production Value Market Share (2018-2023)
Table 35. United States Based Manufacturers Recombinant Antihemophilic Globulin Production (2018-2023) & (Units)
Table 36. United States Based Manufacturers Recombinant Antihemophilic Globulin Production Market Share (2018-2023)
Table 37. China Based Recombinant Antihemophilic Globulin Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Recombinant Antihemophilic Globulin Production Value, (2018-2023) & (USD Million)
Table 39. China Based Manufacturers Recombinant Antihemophilic Globulin Production Value Market Share (2018-2023)
Table 40. China Based Manufacturers Recombinant Antihemophilic Globulin Production (2018-2023) & (Units)
Table 41. China Based Manufacturers Recombinant Antihemophilic Globulin Production Market Share (2018-2023)
Table 42. Rest of World Based Recombinant Antihemophilic Globulin Manufacturers, Headquarters and Production Site (States, Country)
Table 43. Rest of World Based Manufacturers Recombinant Antihemophilic Globulin Production Value, (2018-2023) & (USD Million)
Table 44. Rest of World Based Manufacturers Recombinant Antihemophilic Globulin Production Value Market Share (2018-2023)
Table 45. Rest of World Based Manufacturers Recombinant Antihemophilic Globulin Production (2018-2023) & (Units)
Table 46. Rest of World Based Manufacturers Recombinant Antihemophilic Globulin Production Market Share (2018-2023)
Table 47. World Recombinant Antihemophilic Globulin Production Value by Type, (USD Million), 2018 & 2022 & 2029
Table 48. World Recombinant Antihemophilic Globulin Production by Type (2018-2023) & (Units)
Table 49. World Recombinant Antihemophilic Globulin Production by Type (2024-2029) & (Units)
Table 50. World Recombinant Antihemophilic Globulin Production Value by Type (2018-2023) & (USD Million)
Table 51. World Recombinant Antihemophilic Globulin Production Value by Type (2024-2029) & (USD Million)
Table 52. World Recombinant Antihemophilic Globulin Average Price by Type (2018-2023) & (US$/Unit)
Table 53. World Recombinant Antihemophilic Globulin Average Price by Type (2024-2029) & (US$/Unit)
Table 54. World Recombinant Antihemophilic Globulin Production Value by Application, (USD Million), 2018 & 2022 & 2029
Table 55. World Recombinant Antihemophilic Globulin Production by Application (2018-2023) & (Units)
Table 56. World Recombinant Antihemophilic Globulin Production by Application (2024-2029) & (Units)
Table 57. World Recombinant Antihemophilic Globulin Production Value by Application (2018-2023) & (USD Million)
Table 58. World Recombinant Antihemophilic Globulin Production Value by Application (2024-2029) & (USD Million)
Table 59. World Recombinant Antihemophilic Globulin Average Price by Application (2018-2023) & (US$/Unit)
Table 60. World Recombinant Antihemophilic Globulin Average Price by Application (2024-2029) & (US$/Unit)
Table 61. Shire (Baxter) Basic Information, Manufacturing Base and Competitors
Table 62. Shire (Baxter) Major Business
Table 63. Shire (Baxter) Recombinant Antihemophilic Globulin Product and Services
Table 64. Shire (Baxter) Recombinant Antihemophilic Globulin Production (Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 65. Shire (Baxter) Recent Developments/Updates
Table 66. Shire (Baxter) Competitive Strengths & Weaknesses
Table 67. Bayer Healthcare Basic Information, Manufacturing Base and Competitors
Table 68. Bayer Healthcare Major Business
Table 69. Bayer Healthcare Recombinant Antihemophilic Globulin Product and Services
Table 70. Bayer Healthcare Recombinant Antihemophilic Globulin Production (Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 71. Bayer Healthcare Recent Developments/Updates
Table 72. Bayer Healthcare Competitive Strengths & Weaknesses
Table 73. CSL Basic Information, Manufacturing Base and Competitors
Table 74. CSL Major Business
Table 75. CSL Recombinant Antihemophilic Globulin Product and Services
Table 76. CSL Recombinant Antihemophilic Globulin Production (Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 77. CSL Recent Developments/Updates
Table 78. CSL Competitive Strengths & Weaknesses
Table 79. Pfizer Basic Information, Manufacturing Base and Competitors
Table 80. Pfizer Major Business
Table 81. Pfizer Recombinant Antihemophilic Globulin Product and Services
Table 82. Pfizer Recombinant Antihemophilic Globulin Production (Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 83. Pfizer Recent Developments/Updates
Table 84. Pfizer Competitive Strengths & Weaknesses
Table 85. Grifols Basic Information, Manufacturing Base and Competitors
Table 86. Grifols Major Business
Table 87. Grifols Recombinant Antihemophilic Globulin Product and Services
Table 88. Grifols Recombinant Antihemophilic Globulin Production (Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 89. Grifols Recent Developments/Updates
Table 90. Grifols Competitive Strengths & Weaknesses
Table 91. Biogen Basic Information, Manufacturing Base and Competitors
Table 92. Biogen Major Business
Table 93. Biogen Recombinant Antihemophilic Globulin Product and Services
Table 94. Biogen Recombinant Antihemophilic Globulin Production (Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 95. Biogen Recent Developments/Updates
Table 96. Biogen Competitive Strengths & Weaknesses
Table 97. Octapharma Basic Information, Manufacturing Base and Competitors
Table 98. Octapharma Major Business
Table 99. Octapharma Recombinant Antihemophilic Globulin Product and Services
Table 100. Octapharma Recombinant Antihemophilic Globulin Production (Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 101. Octapharma Recent Developments/Updates
Table 102. Octapharma Competitive Strengths & Weaknesses
Table 103. Novo Nordisk Basic Information, Manufacturing Base and Competitors
Table 104. Novo Nordisk Major Business
Table 105. Novo Nordisk Recombinant Antihemophilic Globulin Product and Services
Table 106. Novo Nordisk Recombinant Antihemophilic Globulin Production (Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 107. Novo Nordisk Recent Developments/Updates
Table 108. Novo Nordisk Competitive Strengths & Weaknesses
Table 109. Greencross Basic Information, Manufacturing Base and Competitors
Table 110. Greencross Major Business
Table 111. Greencross Recombinant Antihemophilic Globulin Product and Services
Table 112. Greencross Recombinant Antihemophilic Globulin Production (Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 113. Greencross Recent Developments/Updates
Table 114. Greencross Competitive Strengths & Weaknesses
Table 115. Kedrion Basic Information, Manufacturing Base and Competitors
Table 116. Kedrion Major Business
Table 117. Kedrion Recombinant Antihemophilic Globulin Product and Services
Table 118. Kedrion Recombinant Antihemophilic Globulin Production (Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 119. Kedrion Recent Developments/Updates
Table 120. Kedrion Competitive Strengths & Weaknesses
Table 121. BPL Basic Information, Manufacturing Base and Competitors
Table 122. BPL Major Business
Table 123. BPL Recombinant Antihemophilic Globulin Product and Services
Table 124. BPL Recombinant Antihemophilic Globulin Production (Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 125. BPL Recent Developments/Updates
Table 126. BPL Competitive Strengths & Weaknesses
Table 127. Hualan Bio Basic Information, Manufacturing Base and Competitors
Table 128. Hualan Bio Major Business
Table 129. Hualan Bio Recombinant Antihemophilic Globulin Product and Services
Table 130. Hualan Bio Recombinant Antihemophilic Globulin Production (Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 131. Hualan Bio Recent Developments/Updates
Table 132. Hualan Bio Competitive Strengths & Weaknesses
Table 133. RAAS Basic Information, Manufacturing Base and Competitors
Table 134. RAAS Major Business
Table 135. RAAS Recombinant Antihemophilic Globulin Product and Services
Table 136. RAAS Recombinant Antihemophilic Globulin Production (Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 137. RAAS Recent Developments/Updates
Table 138. Baxalta Basic Information, Manufacturing Base and Competitors
Table 139. Baxalta Major Business
Table 140. Baxalta Recombinant Antihemophilic Globulin Product and Services
Table 141. Baxalta Recombinant Antihemophilic Globulin Production (Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 142. Global Key Players of Recombinant Antihemophilic Globulin Upstream (Raw Materials)
Table 143. Recombinant Antihemophilic Globulin Typical Customers
Table 144. Recombinant Antihemophilic Globulin Typical Distributors
List of Figure
Figure 1. Recombinant Antihemophilic Globulin Picture
Figure 2. World Recombinant Antihemophilic Globulin Production Value: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Recombinant Antihemophilic Globulin Production Value and Forecast (2018-2029) & (USD Million)
Figure 4. World Recombinant Antihemophilic Globulin Production (2018-2029) & (Units)
Figure 5. World Recombinant Antihemophilic Globulin Average Price (2018-2029) & (US$/Unit)
Figure 6. World Recombinant Antihemophilic Globulin Production Value Market Share by Region (2018-2029)
Figure 7. World Recombinant Antihemophilic Globulin Production Market Share by Region (2018-2029)
Figure 8. North America Recombinant Antihemophilic Globulin Production (2018-2029) & (Units)
Figure 9. Europe Recombinant Antihemophilic Globulin Production (2018-2029) & (Units)
Figure 10. China Recombinant Antihemophilic Globulin Production (2018-2029) & (Units)
Figure 11. Japan Recombinant Antihemophilic Globulin Production (2018-2029) & (Units)
Figure 12. Recombinant Antihemophilic Globulin Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Recombinant Antihemophilic Globulin Consumption (2018-2029) & (Units)
Figure 15. World Recombinant Antihemophilic Globulin Consumption Market Share by Region (2018-2029)
Figure 16. United States Recombinant Antihemophilic Globulin Consumption (2018-2029) & (Units)
Figure 17. China Recombinant Antihemophilic Globulin Consumption (2018-2029) & (Units)
Figure 18. Europe Recombinant Antihemophilic Globulin Consumption (2018-2029) & (Units)
Figure 19. Japan Recombinant Antihemophilic Globulin Consumption (2018-2029) & (Units)
Figure 20. South Korea Recombinant Antihemophilic Globulin Consumption (2018-2029) & (Units)
Figure 21. ASEAN Recombinant Antihemophilic Globulin Consumption (2018-2029) & (Units)
Figure 22. India Recombinant Antihemophilic Globulin Consumption (2018-2029) & (Units)
Figure 23. Producer Shipments of Recombinant Antihemophilic Globulin by Manufacturer Revenue ($MM) and Market Share (%): 2022
Figure 24. Global Four-firm Concentration Ratios (CR4) for Recombinant Antihemophilic Globulin Markets in 2022
Figure 25. Global Four-firm Concentration Ratios (CR8) for Recombinant Antihemophilic Globulin Markets in 2022
Figure 26. United States VS China: Recombinant Antihemophilic Globulin Production Value Market Share Comparison (2018 & 2022 & 2029)
Figure 27. United States VS China: Recombinant Antihemophilic Globulin Production Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Recombinant Antihemophilic Globulin Consumption Market Share Comparison (2018 & 2022 & 2029)
Figure 29. United States Based Manufacturers Recombinant Antihemophilic Globulin Production Market Share 2022
Figure 30. China Based Manufacturers Recombinant Antihemophilic Globulin Production Market Share 2022
Figure 31. Rest of World Based Manufacturers Recombinant Antihemophilic Globulin Production Market Share 2022
Figure 32. World Recombinant Antihemophilic Globulin Production Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 33. World Recombinant Antihemophilic Globulin Production Value Market Share by Type in 2022
Figure 34. Baikoc
Figure 35. Afstyla
Figure 36. Altuviiio
Figure 37. World Recombinant Antihemophilic Globulin Production Market Share by Type (2018-2029)
Figure 38. World Recombinant Antihemophilic Globulin Production Value Market Share by Type (2018-2029)
Figure 39. World Recombinant Antihemophilic Globulin Average Price by Type (2018-2029) & (US$/Unit)
Figure 40. World Recombinant Antihemophilic Globulin Production Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 41. World Recombinant Antihemophilic Globulin Production Value Market Share by Application in 2022
Figure 42. Clinical Treatment
Figure 43. Drug Research
Figure 44. Others
Figure 45. World Recombinant Antihemophilic Globulin Production Market Share by Application (2018-2029)
Figure 46. World Recombinant Antihemophilic Globulin Production Value Market Share by Application (2018-2029)
Figure 47. World Recombinant Antihemophilic Globulin Average Price by Application (2018-2029) & (US$/Unit)
Figure 48. Recombinant Antihemophilic Globulin Industry Chain
Figure 49. Recombinant Antihemophilic Globulin Procurement Model
Figure 50. Recombinant Antihemophilic Globulin Sales Model
Figure 51. Recombinant Antihemophilic Globulin Sales Channels, Direct Sales, and Distribution
Figure 52. Methodology
Figure 53. Research Process and Data Source
